146 related articles for article (PubMed ID: 15548848)
21. Transport of xanthurenic acid by rat/human organic anion transporters OAT1 and OAT3.
Uwai Y; Honjo E
Biosci Biotechnol Biochem; 2013; 77(7):1517-21. PubMed ID: 23832370
[TBL] [Abstract][Full Text] [Related]
22. Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter.
Uwai Y; Saito H; Inui K
Eur J Pharmacol; 2000 Dec; 409(1):31-6. PubMed ID: 11099697
[TBL] [Abstract][Full Text] [Related]
23. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3).
Hong SS; Seo K; Lim SC; Han HK
Pharmacol Res; 2007 Dec; 56(6):468-73. PubMed ID: 17920288
[TBL] [Abstract][Full Text] [Related]
24. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
Wang L; Pan X; Sweet DH
Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
Iwaki M; Shimada H; Irino Y; Take M; Egashira S
Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of selective cyclooxygenase-2 inhibitor etoricoxib on human organic anion transporter 3 (hOAT3).
Honjo H; Uwai Y; Iwamoto K
Drug Metab Lett; 2011 Apr; 5(2):140-37. PubMed ID: 21457143
[TBL] [Abstract][Full Text] [Related]
27. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
Uwai Y; Ida H; Tsuji Y; Katsura T; Inui K
Pharm Res; 2007 Apr; 24(4):811-5. PubMed ID: 17372702
[TBL] [Abstract][Full Text] [Related]
28. Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
Motohashi H; Uwai Y; Hiramoto K; Okuda M; Inui K
Eur J Pharmacol; 2004 Oct; 503(1-3):25-30. PubMed ID: 15496291
[TBL] [Abstract][Full Text] [Related]
29. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.
Ueo H; Motohashi H; Katsura T; Inui K
Biochem Pharmacol; 2005 Oct; 70(7):1104-13. PubMed ID: 16098483
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells.
Maeda A; Tsuruoka S; Kanai Y; Endou H; Saito K; Miyamoto E; Fujimura A
Eur J Pharmacol; 2008 Oct; 596(1-3):166-72. PubMed ID: 18789319
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices.
Nozaki Y; Kusuhara H; Kondo T; Hasegawa M; Shiroyanagi Y; Nakazawa H; Okano T; Sugiyama Y
J Pharmacol Exp Ther; 2007 Apr; 321(1):362-9. PubMed ID: 17255469
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.
Wolff NA; Burckhardt BC; Burckhardt G; Oellerich M; Armstrong VW
Nephrol Dial Transplant; 2007 Sep; 22(9):2497-503. PubMed ID: 17526543
[TBL] [Abstract][Full Text] [Related]
33. Time-Dependent Inhibition of hOAT1 and hOAT3 by Anthraquinones.
Ma L; Qin Y; Shen Z; Hu H; Zhou H; Yu L; Jiang H; Zeng S
Biol Pharm Bull; 2015; 38(7):992-5. PubMed ID: 26133709
[TBL] [Abstract][Full Text] [Related]
34. Uptake of chemically reactive, DNA-damaging sulfuric acid esters into renal cells by human organic anion transporters.
Bakhiya N; Stephani M; Bahn A; Ugele B; Seidel A; Burckhardt G; Glatt H
J Am Soc Nephrol; 2006 May; 17(5):1414-21. PubMed ID: 16597690
[TBL] [Abstract][Full Text] [Related]
35. Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization.
Duan P; Li S; Ai N; Hu L; Welsh WJ; You G
Mol Pharm; 2012 Nov; 9(11):3340-6. PubMed ID: 22973893
[TBL] [Abstract][Full Text] [Related]
36. Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form.
Takekuma Y; Kakiuchi H; Yamazaki K; Miyauchi S; Kikukawa T; Kamo N; Ganapathy V; Sugawara M
J Pharm Pharm Sci; 2007; 10(1):71-85. PubMed ID: 17498396
[TBL] [Abstract][Full Text] [Related]
37. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
38. Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites.
Alebouyeh M; Takeda M; Onozato ML; Tojo A; Noshiro R; Hasannejad H; Inatomi J; Narikawa S; Huang XL; Khamdang S; Anzai N; Endou H
J Pharmacol Sci; 2003 Dec; 93(4):430-6. PubMed ID: 14737013
[TBL] [Abstract][Full Text] [Related]
39. The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1.
Whitley AC; Sweet DH; Walle T
Drug Metab Dispos; 2005 Aug; 33(8):1097-100. PubMed ID: 15870380
[TBL] [Abstract][Full Text] [Related]
40. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.
Kimura H; Takeda M; Narikawa S; Enomoto A; Ichida K; Endou H
J Pharmacol Exp Ther; 2002 Apr; 301(1):293-8. PubMed ID: 11907186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]